Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft.
Landuzzi L, Palladini A, Ceccarelli C, Asioli S, Nicoletti G, Giusti V, Ruzzi F, Ianzano ML, Scalambra L, Laranga R, Balboni T, Arigoni M, Olivero M, Calogero RA, De Giovanni C, Dall'Ora M, Di Oto E, Santini D, Foschini MP, Cucchi MC, Zanotti S, Taffurelli M, Nanni P, Lollini PL.
Landuzzi L, et al. Among authors: ruzzi f.
Sci Rep. 2021 Jan 15;11(1):1563. doi: 10.1038/s41598-021-81085-y.
Sci Rep. 2021.
PMID: 33452364
Free PMC article.